Edge Therapeutics, Inc. (36) | Collaboration Agreements (3)
- First Amendment to Preclinical/Clinical Collaboration and License Agreement dated as of November 22, 2021 by and between PDS Biotechnology Corporation and Farmacore Biotechnology (Filed With SEC on August 8, 2022)
- Amended and Restated Preclinical/Clinical Collaboration and License Agreement dated as of November 30, 2020 by and between PDS Biotechnology Corporation and Farmacore Biotechnology (Filed With SEC on August 8, 2022)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated as of October 28, 2019, by and between PDS Biotechnology Corporation and MSD International GmbH (Filed With SEC on November 7, 2019)
